Cytokine-induced nitric oxide formation in normal but not in neoplastic murine lung epithelial cell lines

被引:17
作者
Thompson, DC
Porter, SE
Bauer, AK
Das, KC
Ou, B
Dwyer-Nield, L
White, CW
Malkinson, AM
机构
[1] Univ Colorado, Sch Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA
[3] Natl Jewish Ctr Immunol & Resp Med, Dept Pediat, Denver, CO 80206 USA
关键词
neoplasia;
D O I
10.1152/ajplung.1998.274.6.L922
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
Cytomix, a mixture of interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta, induces nitric oxide (NO) production in lung epithelial cell lines. It is not known whether neoplastic transformation alters a cell's ability to form NO in response to cytokines. The present study investigated NO formation in two murine lines of immortalized "normal" (nontumorigenic) lung epithelial cells of alveolar type II origin, E10 and C10, and their sibling spontaneous transformants, E9 and A5. Nontumorigenic cells elaborated much more NO after cytomix exposure than did their tumorigenic counterparts. NO production was prevented by inhibiting protein synthesis and NO synthase and attenuated by dexamethasone. Northern and Western blot analyses of inducible NO synthase (iNOS) demonstrated cytomix-induced induction of iNOS only in nontumorigenic cells. The deficiency in NO production in tumorigenic cells was not associated with reduced iNOS mRNA stability or with differences in cytomix-induced nuclear factor-kappa B activation. Although cytomix caused a greater production of NO in E10 cells than in E9 cells, the same treatment induced equivalent proliferation in both cell lines. These results indicate a specific deficiency in cytokine-induced NO synthesis in transformed murine lung epithelial cells relative to their normal progenitor cells and provide a model for investigating iNOS regulation.
引用
收藏
页码:L922 / L932
页数:11
相关论文
共 68 条
[1]
Adcock I M, 1997, Monaldi Arch Chest Dis, V52, P178
[2]
ARIASDIAZ J, 1994, CANCER, V74, P1546, DOI 10.1002/1097-0142(19940901)74:5<1546::AID-CNCR2820740509>3.0.CO
[3]
2-F
[4]
CONSTITUTIVE AND INDUCIBLE NITRIC-OXIDE SYNTHASE GENE-EXPRESSION, REGULATION, AND ACTIVITY IN HUMAN LUNG EPITHELIAL-CELLS [J].
ASANO, K ;
CHEE, CBE ;
GASTON, B ;
LILLY, CM ;
GERARD, C ;
DRAZEN, JM ;
STAMLER, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :10089-10093
[5]
BANI D, 1995, CANCER RES, V55, P5272
[6]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]
Dose- and time-dependent activation of rat alveolar macrophages by glucocorticoids [J].
BrougHolub, E ;
Kraal, G .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (02) :332-336
[8]
Brown T., 1997, CURRENT PROTOCOLS MO
[9]
Advanced glycosylation end products in diabetic renal and vascular disease [J].
Bucala, R ;
Vlassara, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (06) :875-888
[10]
CHEMOSENSITIVITY TESTING OF HUMAN-LUNG CANCER CELL-LINES USING THE MTT ASSAY [J].
CARMICHAEL, J ;
MITCHELL, JB ;
DEGRAFF, WG ;
GAMSON, J ;
GAZDAR, AF ;
JOHNSON, BE ;
GLATSTEIN, E ;
MINNA, JD .
BRITISH JOURNAL OF CANCER, 1988, 57 (06) :540-547